| KCNK14 Protein |
|---|
| Protein Name | Potassium Two Pore Domain Channel Subfamily K Member 14 |
| Gene | KCNK14 (also called K2P14 or TASK-4) |
| UniProt ID | Q9HBU8 |
| Alternative Names | TASK-4, K2P14.1, Two-pore domain potassium channel TASK-4 |
| Molecular Weight | ~45 kDa |
| Subcellular Localization | Plasma membrane |
| Protein Family | Tandem pore domain potassium channel (K2P) family |
KCNK14 (also known as TASK-4) is a member of the two-pore domain potassium (K2P) channel family. These channels generate background potassium currents that regulate neuronal excitability, maintain resting membrane potential, and enable cellular responses to metabolic stress. KCNK14 has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions through its critical roles in neuronal survival, neuroinflammation, and cellular stress responses.
¶ Structure and Function
KCNK14 belongs to the K2P channel family characterized by:
- Four transmembrane segments: Two pore-forming domains (P1 and P2) that create the ion conduction pathway
- Two selectivity filters: The channel passes potassium ions with high selectivity
- Extracellular loops: Form the channel entrance and contribute to ion selectivity
- Cytoplasmic N- and C-termini: Contain regulatory domains that modulate channel activity
KCNK14 is regulated by multiple physiological stimuli:
- pH sensitivity: Intracellular pH modulates channel activity through protonation sites
- Volatile anesthetics: Activated by halogenated anesthetics, contributing to sedation
- Hypoxia: Oxygen levels directly affect channel function, linking metabolism to excitability
- Mechanical stretch: Exhibits mechanosensitivity similar to baroreceptor neurons
KCNK14 contributes to AD pathogenesis through several interconnected mechanisms:
- Neuronal hyperexcitability: Reduced KCNK14 activity may contribute to network hyperactivity observed in early AD
- Calcium dysregulation: Altered potassium flux affects calcium homeostasis through voltage-gated calcium channels
- Amyloid-beta interactions: Amyloid-beta may directly or indirectly modulate KCNK14 function
- Synaptic dysfunction: Potassium channel alterations affect synaptic transmission and plasticity
In Parkinson's disease, KCNK14 plays essential roles in:
- Dopaminergic neuron survival: KCNK14 contributes to survival of substantia nigra dopamine neurons
- Oxidative stress response: Channels modulate cellular responses to oxidative stress
- Mitochondrial function: Interactions with mitochondrial potassium channels affect neuronal metabolism
- Neuroinflammation: Microglial KCNK14 influences inflammatory responses
KCNK14 dysfunction critically contributes to excitotoxic neurodegeneration:
- Resting membrane potential: Loss of KCNK14 depolarizes neurons
- Calcium influx: Depolarization increases NMDA receptor activity and calcium entry
- Energy failure: Excitotoxicity accelerates neuronal death through calcium overload
- Therapeutic implications: KCNK14 modulators may provide neuroprotection
KCNK14 represents a promising therapeutic target for neurodegenerative diseases:
- Channel activators: Opening KCNK14 could reduce neuronal excitability and provide protection
- Protective strategies: Enhancing KCNK14 function may protect against excitotoxicity
- Selectivity challenges: Developing subtype-selective K2P modulators remains challenging
Key challenges in targeting KCNK14 for CNS disorders:
- Blood-brain barrier penetration: Achieving adequate CNS drug delivery
- Isoform selectivity: Distinguishing between 15 K2P family members
- Functional understanding: Further research needed on channel physiology